Instrument Fundamentals
Date | Close | Change | Change (%) | Open | High | Low |
---|
News
AbbVie stock target cut, keeps Buy rating on growth outlook By Investing.com
Empirical Asset Management LLC Boosts Stake in AbbVie Inc. (NYSE:ABBV)
FY2024 Earnings Forecast for AbbVie Issued By Zacks Research
Carnegie Investment Counsel Purchases 5,592 Shares of AbbVie Inc. (NYSE:ABBV)
Tallon Kerry Patrick Buys New Shares in AbbVie Inc. (NYSE:ABBV)
Mason & Associates Inc Acquires 1,499 Shares of AbbVie Inc. (NYSE:ABBV)
StrongBox Wealth LLC Has $699,000 Stake in AbbVie Inc. (NYSE:ABBV)
AbbVie Inc. (NYSE:ABBV) Stake Lessened by StrongBox Wealth LLC
AbbVie's SWOT analysis: stock outlook amid Humira erosion and pipeline growth By Investing.com
Winch Advisory Services LLC Cuts Stake in AbbVie Inc. (NYSE:ABBV)
BMO maintains AbbVie stock Outperform rating By Investing.com
Campbell Newman Asset Management Inc. Cuts Stock Position in AbbVie Inc. (NYSE:ABBV)
Humira Holds Firm at 72% Market Share--AbbVie Fends Off Biosimilar Surge
AbbVie Inc. (NYSE:ABBV) Shares Purchased by Kathmere Capital Management LLC
AbbVie Inc. (NYSE:ABBV) Shares Purchased by BluePath Capital Management LLC
Sawyer & Company Inc Sells 3,161 Shares of AbbVie Inc. (NYSE:ABBV)
Wolff Wiese Magana LLC Acquires 1,750 Shares of AbbVie Inc. (NYSE:ABBV)
The Zacks Analyst Blog Highlights Visa, AbbVie, Analog Devices and Precipio - January 16, 2025 - Zacks.com
5,663 Shares in AbbVie Inc. (NYSE:ABBV) Bought by Pines Wealth Management LLC
AbbVie Inc. (NYSE:ABBV) Shares Sold by SeaCrest Wealth Management LLC
Assenagon Asset Management S.A. Sells 107,872 Shares of AbbVie Inc. (NYSE:ABBV)
Floyd Financial Group LLC Invests $774,000 in AbbVie Inc. (NYSE:ABBV)
Pines Wealth Management LLC Acquires Shares of 5,663 AbbVie Inc. (NYSE:ABBV)
AbbVie Inc. (NYSE:ABBV) Shares Sold by Hummer Financial Advisory Services Inc
Stock Traders Purchase Large Volume of AbbVie Call Options (NYSE:ABBV)
Elevated Capital Advisors LLC Purchases 1,377 Shares of AbbVie Inc. (NYSE:ABBV)
BCS Wealth Management Grows Holdings in AbbVie Inc. (NYSE:ABBV)
BCS Wealth Management Boosts Stake in AbbVie Inc. (NYSE:ABBV)
Wright Investors Service Inc. Trims Holdings in AbbVie Inc. (NYSE:ABBV)
AbbVie secures option to license Simcere's blood cancer drug candidate
26,496 Shares in AbbVie Inc. (NYSE:ABBV) Purchased by Benson Investment Management Company Inc.
AbbVie Inc. (NYSE:ABBV) Shares Purchased by Tsfg LLC
AbbVie Inc. (NYSE:ABBV) Stock Position Boosted by Miracle Mile Advisors LLC
AbbVie Inc. (NYSE:ABBV) Shares Acquired by Eastern Bank
ET Pharma: Pharma News | Latest Pharma Sector Information and Updates
Flurry of Acquisitions and Licensing Deals Come Amid JP Morgan Healthcare Conference 2025
AbbVie Falls 8% in 3 Months: Buy, Hold or Sell the Stock? - January 14, 2025 - Zacks.com
AbbVie Inc. (NYSE:ABBV) Holdings Cut by Brookstone Capital Management
Wedmont Private Capital Buys 3,654 Shares of AbbVie Inc. (NYSE:ABBV)
AbbVie Inc. (NYSE:ABBV) Shares Purchased by Talbot Financial LLC
AbbVie Inc. (NYSE:ABBV) is Agate Pass Investment Management LLC's 3rd Largest Position
AbbVie And Simcere Zaiming Partner To Develop Innovative Cancer Drug SIM0500
AbbVie Inc. (NYSE:ABBV) Shares Sold by Brookstone Capital Management
Caplyta to J&J with $14.6B buyout of Intra-Cellular | BioWorld
AbbVie Inc. (NYSE:ABBV) Shares Bought by Fiduciary Alliance LLC
AbCellera Expands Discovery Partnership With AbbVie | Morningstar
Simcere Zaiming and AbbVie Announce Partnership to Develop a Novel Trispecific Antibody Candidate in Multiple Myeloma | The Manila Times
AbbVie and REGENXBIO Announce Updates on the ABBV-RGX-314 Cl
AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology By Investing.com
Czech National Bank Has $68.09 Million Stake in AbbVie Inc. (NYSE:ABBV)
AbbVie, REGENXBIO advance gene therapy for eye diseases By Investing.com
AbbVie records $3.5 billion impairment charge By Investing.com
AbbVie and Simcere Zaiming Announce Partnership to Develop a Novel Trispecific Antibody Candidate in Multiple Myeloma | PressReleasePoint
Abbvie and Simcere enter a $1B T-cell engager deal | BioWorld
AbbVie Inc. (NYSE:ABBV) Given Consensus Recommendation of "Moderate Buy" by Brokerages
National Taiwan University Hospital and AbbVie Biopharma to strengthen digital strategies for clinical trials
Abbvie to record $3.5 bln charge related to schizophrenia drug, ETPharma
Health Care Down on Defensive Bias - Health Care Roundup | Morningstar
HBW Advisory Services LLC Buys 198 Shares of AbbVie Inc. (NYSE:ABBV)
AbbVie Inc. (NYSE:ABBV) Position Lifted by LVM Capital Management Ltd. MI
AbbVie Inc. (NYSE:ABBV) Shares Bought by HBW Advisory Services LLC
AbbVie Inc. (NYSE:ABBV) Shares Sold by Franklin Street Advisors Inc. NC
Baker Tilly Wealth Management LLC Boosts Position in AbbVie Inc. (NYSE:ABBV)
AbbVie (ABBV) Announces $3.5 Billion Impairment Charge on Emraclidine Asset
AbbVie to Record $3.5 Billion Charge on Failed Cerevel Drug (1)
AbbVie to record $3.5B impairment charge related to the emraclidine By Investing.com
AbbVie to record $3.5 billion impairment charge on emraclidine asset By Investing.com
Rep. Virginia Foxx Sells Off Shares of FLEX LNG Ltd. (NYSE:FLNG)
Rep. Virginia Foxx Buys AbbVie Inc. (NYSE:ABBV) Shares
Rep. Virginia Foxx Unloads Shares of Via Renewables, Inc. (NASDAQ:VIASP)
Rep. Virginia Foxx Sells Via Renewables, Inc. (NASDAQ:VIASP) Stock
AbbVie Inc (ABBV) to Present at J.P. Morgan Healthcare Conference
Parkinson's Disease Treatment Market Size in the US was ~USD 1,883 million in 2023 and it is expected to grow by 2034 | DelveInsight
8,318 Shares in AbbVie Inc. (NYSE:ABBV) Bought by InvesTrust
Fulton Bank N.A. Raises Stock Holdings in AbbVie Inc. (NYSE:ABBV)
Worth Asset Management LLC Has $269,000 Holdings in AbbVie Inc. (NYSE:ABBV)
AbbVie (NYSE:ABBV) Releases Q4 2024 Earnings Guidance
Truist Financial Lowers AbbVie (NYSE:ABBV) Price Target to $211.00
Leerink Partnrs Weighs in on AbbVie FY2029 Earnings
AbbVie Inc. (NYSE:ABBV) Shares Acquired by Innova Wealth Partners
Truist cuts AbbVie stock target, buy rating on positive outlook By Investing.com
Truist Financial Sticks to Its Buy Rating for AbbVie (ABBV)
AbbVie price target lowered to $211 from $215 at Truist
Diversified Trust Co Has $7.44 Million Stake in AbbVie Inc. (NYSE:ABBV)
Diversified Trust Co Buys 1,904 Shares of AbbVie Inc. (NYSE:ABBV)
Capsida Announces AbbVie Opt-in for First Genetic Medicine Program from Neurodegenerative Disease Collaboration | Morningstar
AbbVie (ABBV) Stock Moves -0.32%: What You Should Know - January 7, 2025 - Zacks.com
AbbVie Cuts 2024 EPS Guidance to Include Acquisition Costs - January 7, 2025 - Zacks.com
Will AbbVie (ABBV) Beat Estimates Again in Its Next Earnings Report? - January 7, 2025 - Zacks.com
AbbVie cuts Q4, FY24 adjusted EPS views due to acquisition expenses
AbbVie (NYSE:ABBV) Issues FY 2024 Earnings Guidance
AbbVie (NYSE:ABBV) Issues Q4 2024 Earnings Guidance
AbbVie Inc. (NYSE:ABBV) Shares Bought by Advance Capital Management Inc.
AbbVie says Q4 EPS expected to include acquired IPR&D and milestones expense of $1.6 billion By Investing.com
AbbVie (NYSE:ABBV) Updates FY 2024 Earnings Guidance
Ocular Hypertension Therapeutics Market Size in the 7MM is expected to experience major growth by 2034, estimates DelveInsight
Latest news
Bitcoin Price Action Muted: A Complete Guide on How to Buy Bitcoins in the UK
Week Ahead: Japanese CPI and the BoJ rate hike on the watch, All eyes on the Canada inflation and Trump inauguration